jrnl2727

Publication Venue For

  • Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement 2020
  • 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.  69:1504-1519. 2019
  • Hepatitis B Therapy as HIV Prevention in Africa: A Case Series From Zambia.  69:458-460. 2019
  • Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.  67:524-533. 2018
  • Reply.  66:1002-1003. 2017
  • An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.  65:1196-1205. 2017
  • Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.  65:44-53. 2017
  • Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.  62:932-954. 2015
  • Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.  62:773-783. 2015
  • Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism.  61:497-505. 2015
  • Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.  61:776-782. 2015
  • Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.  59:1084-1093. 2014
  • Hepatitis C virus transmission risk in incarcerated or detained populations.  59:733-733. 2014
  • Steroid use in acute liver failure.  59:612-621. 2014
  • Liver transplantation in the management of porphyria.  60:1082-1089. 2014
  • Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.  60:1620-1636. 2014
  • High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase.  58:1632-1643. 2013
  • Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice.  56:894-903. 2012
  • CHRONIC ALCOHOL CONSUMPTION DISRUPTS THE CIRCADIAN CLOCK IN THE LIVER BUT NOT IN THE SUPRACHIASMATIC NUCLEUS.  54:969A-969A. 2011
  • Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis.  54:153-163. 2011
  • Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.  51:2077-2085. 2010
  • Immature myeloid cells induced by a high-fat diet contribute to liver inflammation.  50:1412-1420. 2009
  • CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection.  50:735-742. 2009
  • Recruitment of host progenitor cells in rat liver transplants.  49:587-597. 2009
  • PIOGLITAZONE PREVENTS OBESITY-INDUCED MITOCHONDRIAL DYSFUNCTION IN LIVER OF THE DIABETIC ZUCKER FATTY RAT.  48:830A-830A. 2008
  • Screening for Wilson disease in acute liver failure: A comparison of currently available diagnostic tests.  48:1167-1174. 2008
  • Minimizing risk associated with elderly liver donors by matching to preferred recipients.  46:1907-1918. 2007
  • Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.  46:1853-1862. 2007
  • Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis.  46:1436-1442. 2007
  • Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via β-catenin activation.  46:1187-1197. 2007
  • Elevated troponin I levels in acute liver failure: Is myocardial injury an integral part of acute liver failure?.  45:1489-1495. 2007
  • Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes.  44:1589-1597. 2006
  • Nitric oxide signaling gone awry: Nitration of glutamine synthetase and hyperammonemia in sepsis.  41:980-982. 2005
  • Chronic alcohol consumption induces the metabolic stress chaperone prohibitin in liver mitochondria..  40:711A-711A. 2004
  • The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice.  40:565-573. 2004
  • The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.  39:1593-1602. 2004
  • HLA and Cytokine Gene Polymorphisms Are independently Associated with Responses to Hepatitis B Vaccination.  39:978-988. 2004
  • A model to predict severe HCV-related disease following liver transplantation.  38:34-41. 2003
  • Chronic alcohol consumption increases the sensitivity of rat liver mitochondrial respiration to inhibition by nitric oxide.  38:141-147. 2003
  • A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.  36:1253-1258. 2002
  • Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.  34:494-501. 2001
  • Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.  33:708-712. 2001
  • Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes.  28:1318-1326. 1998
  • Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome.  23:728-733. 1996
  • Chronic ethanol feeding increases the quantity of Gαs-protein in rat liver plasma membranes.  21:1154-1160. 1995
  • Ischemia‐reperfusion injury: A radical view.  8:680-682. 1988
  • Incarcerate free radicals.  6:536-537. 1986
  • Bile Salt Micelles: Nuclear Magnetic Resonance Spectroscopy and Crystallographic Studies.  4:98S-102S. 1984